×
A Phase 3, Randomized, Open-Label Study Evaluating the Safety and Efficacy of Magrolimab in Combination With Azacitidine in Previously Untreated Patients With TP53-Mutant Acute Myeloid Leukemia
Daver N., Vyas P., Chao MP., Xing G., Renard C., Ramsingh G., Sallman DA., Wei AH.
Type
Conference paper
Publication Date
10/2022
Volume
97
Pages
S5 - S6